ONT-093 - CAS# 216227-54-2 0154 ALK5 and ALK7 (IC50≥500 nM)

ALK5 and ALK7 (IC50≥500 nM) and increases selectivity for BMP signaling versus AMP-activated protein kinase

16)10-4-9-14/h4-8

) exhibits an anti-tumor effect on pancreatic cancer xenografts in mice

Aticaprant (CERC-501) alleviates the nicotine withdrawal syndrome

The decreased expression could be related to the increased liver Fe in both Dp44mT- and 3-AP-treated mice

ONT-093 - CAS# 216227-54-2 0154 ALK5 and ALK7 (IC50≥500 nM)ONT 093, CAS No. 216227 54 2, also known as OC 144 093, is an orally bioavailable P glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy. ONT 093 could inhibit P gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics. OC144 093 is the least non specifically toxic Pgp inhibitor described to date, with an average cytostatic IC50 of >60